Search Within

Marc Ladanyi

Formats
  1. Journal Article (653)
  2. Meeting Abstract (644)
  3. Book Section (13)
  4. Research Letter (8)
  5. Review (7)
  6. Editorial (5)
  7. Guidelines (3)
  8. Conference Paper (1)
  9. Correspondence (1)
  10. Miscellaneous (1)
Groups
  1. Department of Pathology and Laboratory Medicine (1336)
  2. GSK Faculty (1336)
  3. Human Oncology and Pathogenesis Program (1336)
  4. Tow Center for Developmental Oncology (TCDO) (1336)
  5. Department of Medicine (647)
  6. Solid Tumor Oncology Division (618)

More Groups

People
  1. Maria Arcila (303)
  2. Michael Berger (220)
  3. Mark Kris (191)
  4. Gregory Riely (188)
  5. Ahmet Zehir (178)
  6. Natasha Rekhtman (134)

More People

Years
  1. 2025 (23)
  2. 2024 (37)
  3. 2023 (48)
  4. 2022 (72)
  5. 2021 (62)
  6. 2020 (63)

More Years

Publications
  1. Modern Pathology (189)
  2. Laboratory Investigation (155)
  3. Journal of Clinical Oncology (127)
  4. Journal of Molecular Diagnostics (94)
  5. Clinical Cancer Research (87)
  6. Journal of Thoracic Oncology (77)

More Publications

Publishers
  1. Nature Publishing Group (225)
  2. American Association for Cancer Research (202)
  3. Nature Research (191)
  4. American Society of Clinical Oncology (152)
  5. Elsevier Science, Inc. (121)
  6. Elsevier Inc. (97)

More Publishers

Results (1336)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The Hedgehog Signaling Pathway in synovial sarcoma: Mutational and functional analysis
    Meeting Abstract

    Motoi, T.; Saito, T.; Ladanyi, M.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer
    Meeting Abstract

    Balak, M. N.; Riely, G. J.; Li, A. R.; Zakowski, M. F.; Ladanyi, M.; Miller, V. A.; Pao, W.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • An integrated genomic approach to understanding the determinants of mesotheliorna sensitivity to specific novel agents
    Meeting Abstract

    Shimizu, S.; Olshen, A. B.; Krug, L.; Rusch, V.; Ladanyi, M.
    Lung Cancer (2006)

    Fulltext@MSK | Save
  • MET in mesothelioma: Mutational screening, phosphorylation status, and sensitivity to the MET inhibitor PHA-665752
    Meeting Abstract

    Shimizu, S.; Krug, L.; Rusch, V.; Ladanyi, M.
    Lung Cancer (2006)

    Fulltext@MSK | Save
  • The Wnt/beta-catenin signaling pathway in synovial sarcoma: Mutational and functional analysis
    Meeting Abstract

    Saito, T.; Motoi, T.; Ladanyi, M.
    Laboratory Investigation (2006)

    Fulltext@MSK | Save
  • The Wnt/ß-catenin signaling pathway in synovial sarcoma: Mutational and functional analysis
    Meeting Abstract

    Saito, T.; Motoi, T.; Ladanyi, M.
    Modern Pathology (2006)

    Fulltext@MSK | Save
  • Molecular analysis of NSCLC patients with acquired resistance to gefitinib or erlotinib
    Meeting Abstract

    Pao, W.; Balak, M. N.; Riely, G. J.; Li, A. R.; Zakowski, M. F.; Ladanyi, M.; Miller, V. A.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Mutational, immunohistochemical, and functional analysis of the Hedgehog pathway in synovial sarcoma
    Meeting Abstract

    Motoi, T.; Saito, T.; Motoi, N.; Ladanyi, M.
    Modern Pathology (2006)

    Fulltext@MSK | Save
  • The hedgehog signaling pathway in synovial sarcoma: Mutational and functional analysis
    Meeting Abstract

    Motoi, T.; Saito, T.; Ladanyi, M.
    Modern Pathology (2006)

    Fulltext@MSK | Save
  • The Hedgehog signaling pathway in synovial sarcoma: Mutational and functional analysis
    Meeting Abstract

    Motoi, T.; Saito, T.; Ladanyi, M.
    Laboratory Investigation (2006)

    Fulltext@MSK | Save